Fundraising FoxNadav Rosenberg — Full Portfolio
6 tracked investments · listed companies and verified rows first
Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Federico Paoletti(CEO & Co-Founder)inAndrea Mambrini(CTO & Co-Founder)in
Co-investorsBeresford VenturesEntrepreneur FirstJude GomilaSelvedge VentureUnruly CapitalCambridge Angels group+1 more
Flexciton develops AI-driven production planning and scheduling software for semiconductor fabs, using mathematical optimization to improve throughput, tool utilization, and on-time delivery.
Advanced ManufacturingAI & Machine LearningSemiconductorsLondon, GB
Jamie Potter(CEO, Co-Founder)inDionysios Xenos(CTO)inDennis Xenos(CTO, Co-Founder)in
Co-investorsBackedEntrepreneur FirstChalfen VenturesSARAS CAPITAL
Infinitopes develops immunotherapy treatments for cancer, focusing on immune-oncology and antigen discovery solutions aimed at improving patient outcomes and affordability in cancer care.
AI & Machine LearningBiotechHealthtechMedical DevicesOxford, GB
Jonathan Kwok(Co-Founder, President & Chief Medical Officer)inLian Ni Lee(VP Preclinical & Co-Founder)in
Co-investorsAmplify PartnersManta Ray VenturesOctopus VenturesEMV CapitalKindred CapitalMartlet Capital+1 more
Nuntius develops programmable nanocarriers for drug delivery that can target tissues beyond the liver and utilize machine learning to optimize carrier performance.
AI & Machine LearningBiotechDeep TechHealthtechLondon, GB
Benita Nagel(Founder)inAlbert Kwok(Founder)in
Co-investorsBackedY CombinatorAsymmetry VenturesFoundersXHarvard Management CompanyUNCOMMON DENOMINATOR
Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.
AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB
Quin Wills(CSO)inJack O'Meara(Founder)in
BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle
Co-investorsBackedBeast VenturesCoastCapEntrepreneur FirstExpaGaingels+18 more
__Twitter.png)
Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.
BiotechHealthtechNew York City, US
Adam Yaari(CEO)inMaxwell Sherman(CTO)in
Co-investorsIllumina VenturesMetaplanetPioneerSapir Venture PartnersVertex Ventures IsraelY Combinator+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.